← Eichor
Condition: Caa Cerebral Amyloid Angiopathy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Caa Cerebral Amyloid Angiopathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid A
NA · 1 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06714097
Prognosis of Cerebral Small Vessel Disease
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT05734378
SEarchiNg biomarkErs Cerebral Amyloid Angiopathy (SENECA)
Phase N/A · 1 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT04204642
Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral Hemorrhage
Phase 2 · 3 location(s) · Huashan Hospital · NCT07026994
Effect of the Mediterranean Diet in Patients Affected by CADASIL and Cerebral Amyloid Angiopathy.
Phase N/A · 1 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06933212
A Study of AMDX-2011P in Participants With CAA
Phase 2 · 1 location(s) · Amydis Inc. · NCT05709314
Phenotypic and Molecular Characterisation of Cerebral Amyloid Angiopathy
Phase N/A · 1 location(s) · University Hospital, Rouen · NCT06864000
Jiedu Huayu Oral Prescription in the Treatment of Intracranial Hemorrhage Associated With Cerebral Amyloid Angiopathy
Phase 3 · 1 location(s) · Beijing Tiantan Hospital · NCT07250035
A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy
Phase 2 · 57 location(s) · Alnylam Pharmaceuticals · NCT06393712
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.